loadpatents
Patent applications and USPTO patent grants for Brough; Paul Andrew.The latest application filed is for "purine compunds as hsp90 protein inhibitors for the treatment of cancer".
Patent | Date |
---|---|
3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer Grant 7,803,831 - Beswick , et al. September 28, 2 | 2010-09-28 |
Purine Compunds as HSP90 Protein Inhibitors for the Treatment of Cancer App 20090181989 - BROUGH; Paul Andrew ;   et al. | 2009-07-16 |
Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors App 20090163490 - Brough; Paul Andrew ;   et al. | 2009-06-25 |
Pyrimidothiophene Compounds App 20090069336 - Barril-Alonso; Xavier ;   et al. | 2009-03-12 |
Pyrimidothiophene Compounds Having HSP90 Inhibitory Activity App 20090054421 - Matthews; Thomas Peter ;   et al. | 2009-02-26 |
3-(2-Hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer App 20070112192 - Beswick; Mandy Christine ;   et al. | 2007-05-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.